Alendronate prevents bone loss in patients with acute spinal cord injury: A randomized, double-blind, placebo-controlled study

Journal of Clinical Endocrinology and Metabolism

Volumn 92, Issue 4, 2007, Pages 1385-1390

  Gilchrist, N L ^a   Frampton, C M ^b   Acland, R H ^c   Nicholls, M G ^b   March, R L ^a   Maguire, P ^a   Heard, A ^a   Reilly, P ^a   Marshall, K ^c  

^a PRINCESS MARGARET HOSPITAL   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

^c BURWOOD HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; CALCIUM; CARBOXY TERMINAL TELOPEPTIDE; PLACEBO;

ABDOMINAL PAIN; ARTICLE; BONE DENSITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DYSPEPSIA; FEMALE; HUMAN; MALE; NAUSEA; OSTEOLYSIS; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; SPINAL CORD INJURY; URINALYSIS; VOMITING;

EID: 34147138506     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2006-2013     Document Type: Article

References (26)

1. Acton PA, Farley T, Freni LW, Ilegbodu VA, Sniezek JE, Wohlleb JC 1993 Traumatic spinal cord injury in Arkansas, 1980-1989. Arch Phys Med Rehabil 74:1035-1040
2. Shingu H, Ohama M, Ikata T, Katoh S, Akatsu T 1995 A nationwide epidemiological survey of spinal cord injuries in Japan from January 1990 to December 1992. Paraplegia 33:183-188
3. Szollar SM, Martin EM, Parthemore JG, Sartoris DJ, Deftos LJ 1997 Densitometric patterns of spinal cord injury associated bone loss. Spinal Cord 35: 374-382
4. Dauty M, Perrouin Verbe B, Maugars Y, Dubois C, Mathé JF 2000 Supralesional and sublesional bone mineral density in spinal cord injured patients. Bone 27:305-309
5. Roberts D, Lee W, Cuneo RC, Whitman J, Ward G, Flatman R, McWhinney B, Hickman PE 1998 Longitudinal study of bone turnover after acute spinal cord injury. J Clin Endocrinol Metab 83:415-422
6. Maimoun L, Fattal C, Micallef JP, Peruchon E, Rabischong P 2006 Bone loss in spinal cord injured patients: from physiopathology to therapy. Spinal Cord 44:203-210
7. Lazo MG, Shirazi P, Sam M, Giobbie-Hurder A, Blacconiere MJ, Muppidi M 2001 Osteoporosis and risk of fracture in men with spinal cord injury. Spinal Cord 39:208-214
8. Wilmet E, Ismail AA, Heilporn A, Welraeds D, Bergmann P 1995 Longitudinal study of the bone mineral content and of soft tissue composition after spinal cord section. Paraplegia 33:674-677
9. Demirel G, Yilmaz H, Paker N, Önel S 1998 Osteoporosis after spinal cord injury. Spinal Cord 36:822-825
10. Garland DE, Stewart CA, Adkins RH, Hu SS, Rosen C, Liotta RJ, Weinstein DA 1992 Osteoporosis after spinal cord injury. J Orthop Res 10:371-378
11. Minaire P, Mallet E, Levermieux J 1987 Immobilisation bone loss: preventing effect of calcitonin in several clinical models. In: Christiansen C, Riis V, eds. Osteoporosis. Copenhagen: Osteo Press; 603-610
12. Pearson EG, Nance PW, Leslie WD, Ludwig S 1997 Cyclical etidronate:its effect on bone density in patients with acute spinal cord injury. Arch Phys Med Rehabil 78:269-272
13. Chappard D, Minaire P, Privat C, Berard E, Mendoza-Sarmiento J, Tournebise H, Basle MF, Audran M, Rebel A, Picot C, Gaud C 1995 Effects of tiludronate on bone loss in paraplegic patients. J Bone Miner Res 10:112-118
14. Nance PW, Schryvers O, Leslie W, Ludwig S, Krahn J, Uebelhart D 1999 Intravenous pamidronate attenuates bone density loss after acute spinal cord injury. Arch Phys Med Rehabil 80:243-251
15. Kedlaya D, Brandstater ME, Leigh JK 1998 Immobilization hypercalcemia in incomplete paraplegia: successful treatment with pamidronate. Arch Phys Med Rehab 79:222-225
16. Zehnder Y, Risi S, Michel D, Knecht H, Perrelet R, Kraenzlin M, Zach GA, Lippuner K 2004 Prevention of bone loss in paraplegics over 2 years with alendronate. J Bone Miner Res 19:1067-1074
17. Liberman UA, Weiss SR, Broll J, Minne HN, Quan H, Bell NH, Rodriquez-Portales J, Downs RW, Dequeker J, Favus M 1995 Effect of oral alendronate on bone mineral density and the incidence of fracture in post menopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group. N Engl J Med 333:1437-1443
18. Orwoll E, Ettinger M, Weiss S, Miller P, Kendler D, Graham J, Adami S, Weber K, Lorenc R, Pietschmann P, Vandormael K, Lombardi A 2000 Alendronate for the treatment of osteoporosis in men. N Engl J Med 343:604-610
19. Ruml LA, Dubois SK, Roberts ML, Pak CY 1995 Prevention of hypercalciuria and stone-forming propensity during prolonged bedrest by alendronate. J Bone Miner Res 10:655-662
20. Van der Poest Clement E, Van Engeland M, Ader H, Rooss JC, Patka P, Lips P 2002 Alendronate in the prevention of bone loss after fracture of the lower leg. J Bone Miner Res 17:2247-2255
21. Schnitzer T, Bone HG, Crepaldi G, Adami S, McClung M, Kiel D, Felsenberg D, Recker RR, Tonino RP, Roux C, Pinchera A, Foldes AJ, Greespan SL, Levine MA, Emkey R, II Santora, Kaur A, Thompson DE, Yates J, Orloff JJ 2000 Therapeutic equivalence of alendronate 70mg once weekly and alendronate 10mg daily in the treatment of osteoporosis. Alendronate Once Weekly Study Group. Aging Clin Exp Res 12:1-12
22. Eser P, Frotzler A, Zehnder Y, Wick L, Knecht H, Denoth J, Schiessl H 2004 Relationship between the duration of paralysis and bone structure: a pQCT study of spinal cord injured individuals. Bone 34:869-880
23. Biering-Sørensen F, Bohr HH, Schaadt OP 1990 Longitudinal study of bone mineral content in the lumbar spine, forearm and lower extremities after spinal cord injury. Eur J Clin Invest 20:330-335
24. Kunkel CF, Scremin AM, Eisenberg B, Garcia JF, Roberts S, Martinez S 1993 Effect of "standing" on the spasticity, contracture and osteoporosis in paralyzed males. Arch Phys Med Rehabil 74:73-78
25. Jaovisidha S, Sartoris DJ, Martin EME, De Maeseneer M, Szollar SM, Deftos LJ 1997 Influence of spondylopathy on bone densitometry using dual energy x-ray asorptiometry. Calcif Tissue Int 60:424-429
26. Carroll A, Brackenridge P 2005 Post-traumatic syringomyelia: a review of the cases presenting in a regional spinal injuries unit in the north east of England over a 5-year period. Spine 30:1206-1210